Clene Inc.
CLNN • NASDAQ
Clene Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert Etherington, with a market cap of $55.5M.
CEORobert Etherington
Next Earnings
Upcoming earnings announcement for Clene Inc.
Date
Wednesday, May 6, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.60
Revenue Estimate
$36.3K
Earnings History
Past 12 earnings reports for Clene Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$0.88Est: -$0.55 | -60.0% | $77.0KEst: $28.5K | +170.2% |  10-K |
| Nov 13, 2025 | Q3 2025 | -$0.85Est: -$0.58 | -46.6% | $15.0KEst: $65.1K | -77.0% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.78Est: -$0.47 | -66.0% | $27.0KEst: $73.7K | -63.4% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.09Est: -$0.78 | +88.5% | $81.0KEst: $66.7K | +21.5% | 10-Q |
| Mar 24, 2025 | Q4 2024 | -$1.67Est: -$0.87 | -92.0% | $91.0KEst: $156.0K | -41.7% | 10-K |
| Nov 13, 2024 | Q3 2024 | -$1.22Est: -$1.32 | +7.6% | $87.0KEst: $90.0K | -3.3% | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$1.06Est: -$1.60 | +33.8% | $91.0KEst: $70.0K | +30.0% | 10-Q |
| May 8, 2024 | Q1 2024 | -$1.80Est: -$1.60 | -12.5% | $73.0KEst: $120.0K | -39.2% | 10-Q |
| Mar 13, 2024 | Q4 2023 | -$1.20Est: -$1.40 | +14.3% | $170.0KEst: $130.0K | +30.8% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.40Est: -$1.80 | +77.8% | $108.0KEst: $120.0K | -10.0% | — |
| Aug 14, 2023 | Q2 2023 | -$5.80Est: -$2.40 | -141.7% | $269.0KEst: $120.0K | +124.2% | 10-Q |
| May 12, 2023 | Q1 2023 | -$3.00Est: -$2.80 | -7.1% | $107.0KEst: $130.0K | -17.7% | — |